JPS5616486A - Manufacture of oxoalkylxanthine - Google Patents

Manufacture of oxoalkylxanthine

Info

Publication number
JPS5616486A
JPS5616486A JP9883880A JP9883880A JPS5616486A JP S5616486 A JPS5616486 A JP S5616486A JP 9883880 A JP9883880 A JP 9883880A JP 9883880 A JP9883880 A JP 9883880A JP S5616486 A JPS5616486 A JP S5616486A
Authority
JP
Japan
Prior art keywords
oxoalkylxanthine
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9883880A
Other languages
English (en)
Inventor
Furaa Hararuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS5616486A publication Critical patent/JPS5616486A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP9883880A 1979-07-21 1980-07-21 Manufacture of oxoalkylxanthine Pending JPS5616486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792929596 DE2929596A1 (de) 1979-07-21 1979-07-21 Verfahren zur herstellung von oxoalkyl-xanthinen

Publications (1)

Publication Number Publication Date
JPS5616486A true JPS5616486A (en) 1981-02-17

Family

ID=6076378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9883880A Pending JPS5616486A (en) 1979-07-21 1980-07-21 Manufacture of oxoalkylxanthine

Country Status (9)

Country Link
EP (1) EP0023032A1 (ja)
JP (1) JPS5616486A (ja)
AR (1) AR227645A1 (ja)
DE (1) DE2929596A1 (ja)
DK (1) DK311580A (ja)
ES (1) ES8105005A1 (ja)
FI (1) FI802267A7 (ja)
GR (1) GR69741B (ja)
NO (1) NO802173L (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6140288A (ja) * 1984-07-19 1986-02-26 ビーチヤム・ヴエルフイング・ゲーエムベーハー・ウント・コンパニー・カーゲー 医薬組成物
US4851060A (en) * 1987-08-12 1989-07-25 Essex Group, Inc. Multilayer wrapped insulated magnet wire

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
GB8501488D0 (en) * 1985-01-21 1985-02-20 Beecham Group Plc Treatment
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru) 2008-12-23 2015-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Солевые формы органического соединения
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en) 2011-07-15 2020-06-23 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336403A1 (fr) * 1975-12-24 1977-07-22 Bruneau & Cie Lab Nouveau procede de preparation de l'acide (theophyllinyl-7)-3 propanesulfonique
GB1527543A (en) * 1976-04-15 1978-10-04 Degussa Basically substituted xanthine derivatives
DE2714953C2 (de) * 1977-04-02 1986-09-25 Hoechst Ag, 6230 Frankfurt Arzneimittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6140288A (ja) * 1984-07-19 1986-02-26 ビーチヤム・ヴエルフイング・ゲーエムベーハー・ウント・コンパニー・カーゲー 医薬組成物
JPH02160720A (ja) * 1984-07-19 1990-06-20 Beecham Wuelfing Gmbh & Co Kg 医薬組成物
US4851060A (en) * 1987-08-12 1989-07-25 Essex Group, Inc. Multilayer wrapped insulated magnet wire

Also Published As

Publication number Publication date
ES493385A0 (es) 1981-05-16
ES8105005A1 (es) 1981-05-16
AR227645A1 (es) 1982-11-30
DK311580A (da) 1981-01-22
NO802173L (no) 1981-01-22
EP0023032A1 (de) 1981-01-28
FI802267A7 (fi) 1981-01-01
GR69741B (ja) 1982-07-12
DE2929596A1 (de) 1981-02-05

Similar Documents

Publication Publication Date Title
JPS55106264A (en) Manufacture of benzimidazolylbenzofurans
JPS5612360A (en) Manufacture of oosubstituteddketoxime
JPS5640649A (en) Manufacture of diesterdiamide
JPS55130966A (en) Manufacture of thiazolidinee22thione
JPS55154968A (en) Manufacture of epsilonncaprolactone
JPS5625153A (en) Manufacture of methylenecycloamines
JPS55137115A (en) Manufacture of carboxyllatex
JPS55105632A (en) Manufacture of etheralcohol
JPS55133361A (en) Manufacture of hydroxyethylazoles
JPS54100322A (en) Manufacture of nnacyltaurine
JPS5636439A (en) Manufacture of betaaaminopropionamide
JPS55125156A (en) Manufacture of 11aminoo22phenoxyy44hydroxyyanthraquinone
JPS5616419A (en) Manufacture of trifluoromethylnaphthalene
JPS55160770A (en) Manufacture of hexafluorotriarylisocyanurate
JPS55111464A (en) Manufacture of 77acylindolinee22one
JPS5618990A (en) Manufacture of trialkoxysilanols
JPS5626828A (en) Manufacture of 44fluoroo33phenoxyytoluene
JPS5640663A (en) Manufacture of pyrrolee22acetate
JPS5612388A (en) Manufacture of pyrenzepin
JPS56123967A (en) Manufacture of omegaalactam
JPS5620561A (en) Manufacture of benzylcyanides
JPS5610177A (en) Manufacture of 22isopropylaminopyrimidine
JPS5632449A (en) Manufacture of naphthalenesulfonylchloride
JPS5629559A (en) Manufacture of alphaahydroxyoxime
JPS5626880A (en) Manufacture of 22isopropylaminoopyrimidine